{"id":"https://openalex.org/W4408076804","doi":"https://doi.org/10.1007/s12325-024-03069-4","title":"First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study","display_name":"First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study","publication_year":2025,"publication_date":"2025-02-28","ids":{"openalex":"https://openalex.org/W4408076804","doi":"https://doi.org/10.1007/s12325-024-03069-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/40025394","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11929688"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-024-03069-4","doi":"https://doi.org/10.1007/s12325-024-03069-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-03069-4","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1007/s12325-024-03069-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081604639","display_name":"Shukui Qin","orcid":"https://orcid.org/0000-0002-3414-2790","observed_orcids":["https://orcid.org/0000-0002-3414-2790"]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Shukui Qin","raw_affiliation_strings":["Cancer Center of People's Liberation Army, Nanjing, China. qinsk@csco.org.cn","GI Cancer Center, Nanjing Tianyinshan Hospital of China Pharmaceutical University, No 3789, Jieyin Road, Jiangning District, Nanjing, 210000, Jiangsu, China. qinsk@csco.org.cn","Cancer Center of People's Liberation Army, Nanjing, China","GI Cancer Center, Nanjing Tianyinshan Hospital of China Pharmaceutical University, No 3789, Jieyin Road, Jiangning District, Nanjing, 210000, Jiangsu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center of People's Liberation Army, Nanjing, China. qinsk@csco.org.cn","institution_ids":[]},{"raw_affiliation_string":"GI Cancer Center, Nanjing Tianyinshan Hospital of China Pharmaceutical University, No 3789, Jieyin Road, Jiangning District, Nanjing, 210000, Jiangsu, China. qinsk@csco.org.cn","institution_ids":["https://openalex.org/I161716053"]},{"raw_affiliation_string":"Cancer Center of People's Liberation Army, Nanjing, China","institution_ids":[]},{"raw_affiliation_string":"GI Cancer Center, Nanjing Tianyinshan Hospital of China Pharmaceutical University, No 3789, Jieyin Road, Jiangning District, Nanjing, 210000, Jiangsu, China","institution_ids":["https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087661837","display_name":"Yuxian Bai","orcid":"https://orcid.org/0000-0002-5004-7523","observed_orcids":["https://orcid.org/0000-0002-5004-7523"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuxian Bai","raw_affiliation_strings":["Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084593730","display_name":"Jin Li","orcid":"https://orcid.org/0000-0003-0099-874X","observed_orcids":["https://orcid.org/0000-0003-0099-874X"]},"institutions":[{"id":"https://openalex.org/I116953780","display_name":"Tongji University","ror":"https://ror.org/03rc6as71","country_code":"CN","type":"education","lineage":["https://openalex.org/I116953780"]},{"id":"https://openalex.org/I4210128175","display_name":"Shanghai East Hospital","ror":"https://ror.org/038xmzj21","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128175"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jin Li","raw_affiliation_strings":["Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China","institution_ids":["https://openalex.org/I116953780","https://openalex.org/I4210128175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045553246","display_name":"Hongming Pan","orcid":"https://orcid.org/0000-0001-5034-3392","observed_orcids":["https://orcid.org/0000-0001-5034-3392","https://orcid.org/0009-0003-7751-6750"]},"institutions":[{"id":"https://openalex.org/I2802390878","display_name":"Sir Run Run Shaw Hospital","ror":"https://ror.org/00ka6rp58","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802390878"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongming Pan","raw_affiliation_strings":["Zhejiang University School of Medicine, Sir Run Shaw Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang University School of Medicine, Sir Run Shaw Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I2802390878","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100657696","display_name":"Suxia Luo","orcid":"https://orcid.org/0000-0002-8639-7314","observed_orcids":["https://orcid.org/0000-0002-8639-7314","https://orcid.org/0000-0002-8020-4673"]},"institutions":[{"id":"https://openalex.org/I38877650","display_name":"Zhengzhou University","ror":"https://ror.org/04ypx8c21","country_code":"CN","type":"education","lineage":["https://openalex.org/I38877650"]},{"id":"https://openalex.org/I4210143608","display_name":"Henan Cancer Hospital","ror":"https://ror.org/043ek5g31","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210143608"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Suxia Luo","raw_affiliation_strings":["The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China","institution_ids":["https://openalex.org/I38877650","https://openalex.org/I4210143608"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yanli Qu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154093214","display_name":"Xinjiang Medical University","ror":"https://ror.org/01p455v08","country_code":"CN","type":"education","lineage":["https://openalex.org/I154093214"]},{"id":"https://openalex.org/I4210102015","display_name":"Tumor Hospital of Xinjiang Medical University","ror":"https://ror.org/015tqbb95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210102015"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanli Qu","raw_affiliation_strings":["Cancer Hospital Affiliated to Xinjiang Medical University, Xinjiang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Hospital Affiliated to Xinjiang Medical University, Xinjiang, China","institution_ids":["https://openalex.org/I154093214","https://openalex.org/I4210102015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100398498","display_name":"Feng Ye","orcid":"https://orcid.org/0000-0002-9159-7767","observed_orcids":["https://orcid.org/0000-0002-9159-7767"]},"institutions":[{"id":"https://openalex.org/I4210087327","display_name":"First Affiliated Hospital of Xiamen University","ror":"https://ror.org/0006swh35","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210087327"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng Ye","raw_affiliation_strings":["The First Affiliated Hospital of Xiamen University, Xiamen, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Affiliated Hospital of Xiamen University, Xiamen, China","institution_ids":["https://openalex.org/I4210087327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060507935","display_name":"Lin Yang","orcid":"https://orcid.org/0000-0001-8746-9255","observed_orcids":["https://orcid.org/0000-0001-8746-9255"]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]},{"id":"https://openalex.org/I4210141458","display_name":"Cancer Hospital of Chinese Academy of Medical Sciences","ror":"https://ror.org/03x937183","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin Yang","raw_affiliation_strings":["National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China","institution_ids":["https://openalex.org/I200296433","https://openalex.org/I4210141458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100677110","display_name":"Tianshu Liu","orcid":"https://orcid.org/0000-0002-2318-2869","observed_orcids":["https://orcid.org/0000-0002-2318-2869"]},"institutions":[{"id":"https://openalex.org/I24943067","display_name":"Fudan University","ror":"https://ror.org/013q1eq08","country_code":"CN","type":"education","lineage":["https://openalex.org/I24943067"]},{"id":"https://openalex.org/I4210127074","display_name":"Zhongshan Hospital","ror":"https://ror.org/032x22645","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210127074"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tianshu Liu","raw_affiliation_strings":["Zhongshan Hospital Affiliated to Fudan University, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhongshan Hospital Affiliated to Fudan University, Shanghai, China","institution_ids":["https://openalex.org/I24943067","https://openalex.org/I4210127074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100318350","display_name":"W\u011bi Li","orcid":"https://orcid.org/0000-0003-0471-2382","observed_orcids":["https://orcid.org/0000-0003-0471-2382"]},"institutions":[{"id":"https://openalex.org/I4210125137","display_name":"First Hospital of Jilin University","ror":"https://ror.org/034haf133","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210125137"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["The First Hospital of Jilin University, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Hospital of Jilin University, Changchun, China","institution_ids":["https://openalex.org/I4210125137"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100330066","display_name":"Xi Chen","orcid":"https://orcid.org/0009-0000-6053-3851","observed_orcids":["https://orcid.org/0009-0000-6053-3851"]},"institutions":[{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xi Chen","raw_affiliation_strings":["The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Fuzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Fuzhou, China","institution_ids":["https://openalex.org/I4210160531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104028099","display_name":"Jianwei Yang","orcid":"https://orcid.org/0009-0002-7044-4523","observed_orcids":["https://orcid.org/0009-0002-7044-4523","https://orcid.org/0009-0008-6909-5059"]},"institutions":[{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianwei Yang","raw_affiliation_strings":["Fujian Provincial Cancer Hospital, Fuzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujian Provincial Cancer Hospital, Fuzhou, China","institution_ids":["https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048541371","display_name":"Jieer Ying","orcid":"https://orcid.org/0000-0001-9452-1242","observed_orcids":["https://orcid.org/0000-0001-9452-1242"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jieer Ying","raw_affiliation_strings":["Zhejiang Cancer Hospital, Hangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhejiang Cancer Hospital, Hangzhou, China","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077850808","display_name":"Xiaoyan Lin","orcid":"https://orcid.org/0000-0002-6930-7778","observed_orcids":["https://orcid.org/0000-0002-6930-7778"]},"institutions":[{"id":"https://openalex.org/I4210163933","display_name":"Union Hospital","ror":"https://ror.org/055gkcy74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163933"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoyan Lin","raw_affiliation_strings":["Fujian Medical University Union Hospital, Fuzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujian Medical University Union Hospital, Fuzhou, China","institution_ids":["https://openalex.org/I4210163933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101514390","display_name":"Lin Zhao","orcid":"https://orcid.org/0000-0003-2994-2387","observed_orcids":["https://orcid.org/0000-0003-2994-2387"]},"institutions":[{"id":"https://openalex.org/I2801228662","display_name":"Peking Union Medical College Hospital","ror":"https://ror.org/04jztag35","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801228662"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin Zhao","raw_affiliation_strings":["Peking Union Medical College Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking Union Medical College Hospital, Beijing, China","institution_ids":["https://openalex.org/I2801228662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062160614","display_name":"Xinjun Liang","orcid":"https://orcid.org/0000-0003-1693-7706","observed_orcids":["https://orcid.org/0000-0003-1693-7706"]},"institutions":[{"id":"https://openalex.org/I4210160841","display_name":"Hubei Cancer Hospital","ror":"https://ror.org/05p38yh32","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160841"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinjun Liang","raw_affiliation_strings":["Hubei Cancer Hospital, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hubei Cancer Hospital, Wuhan, China","institution_ids":["https://openalex.org/I4210160841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109693686","display_name":"Yixiang Mao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267179","display_name":"MSD (China) Investment Co., Ltd. (China)","ror":"https://ror.org/01hr8kn45","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yixiang Mao","raw_affiliation_strings":["MSD China, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD China, Shanghai, China","institution_ids":["https://openalex.org/I4405267179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113906293","display_name":"Run Guo","orcid":"https://orcid.org/0009-0001-3594-2642","observed_orcids":["https://orcid.org/0009-0001-3594-2642"]},"institutions":[{"id":"https://openalex.org/I4405267179","display_name":"MSD (China) Investment Co., Ltd. (China)","ror":"https://ror.org/01hr8kn45","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Run Guo","raw_affiliation_strings":["MSD China, Beijing, China"],"raw_orcid":"https://orcid.org/0009-0001-3594-2642","affiliations":[{"raw_affiliation_string":"MSD China, Beijing, China","institution_ids":["https://openalex.org/I4405267179"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yi Zuo","orcid":"https://orcid.org/0000-0002-6643-8326","observed_orcids":["https://orcid.org/0000-0002-6643-8326"]},"institutions":[{"id":"https://openalex.org/I4405267179","display_name":"MSD (China) Investment Co., Ltd. (China)","ror":"https://ror.org/01hr8kn45","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi Zuo","raw_affiliation_strings":["MSD China, Beijing, China"],"raw_orcid":"https://orcid.org/0000-0002-6643-8326","affiliations":[{"raw_affiliation_string":"MSD China, Beijing, China","institution_ids":["https://openalex.org/I4405267179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020698248","display_name":"Sonal Bordia","orcid":"https://orcid.org/0000-0003-3753-3882","observed_orcids":["https://orcid.org/0000-0003-3753-3882"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonal Bordia","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025337554","display_name":"Shouguo Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191208505","display_name":"Xiamen University","ror":"https://ror.org/00mcjh785","country_code":"CN","type":"education","lineage":["https://openalex.org/I191208505"]},{"id":"https://openalex.org/I4210124907","display_name":"Zhongshan Hospital of Xiamen University","ror":"https://ror.org/02z125451","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210124907"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shouguo Li","raw_affiliation_strings":["Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China","institution_ids":["https://openalex.org/I191208505","https://openalex.org/I4210124907"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":26,"corresponding_author_ids":["https://openalex.org/A5081604639"],"corresponding_institution_ids":["https://openalex.org/I161716053"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":{"value":4790,"currency":"USD","value_usd":4790},"fwci":6.2702,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.97308521,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"42","issue":"4","first_page":"1892","last_page":"1906"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9649999737739563},{"id":"https://openalex.org/keywords/her2-negative-gastric-cancer","display_name":"HER2-negative gastric cancer","score":0.9819999933242798},{"id":"https://openalex.org/keywords/gastroesophageal-junction-adenocarcinoma","display_name":"gastroesophageal junction adenocarcinoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7440000176429749},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8230000138282776},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9549999833106995},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.8849999904632568},{"id":"https://openalex.org/keywords/metastatic-gastric-cancer","display_name":"metastatic gastric cancer","score":0.6399999856948853},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.531000018119812},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9296396970748901},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7243155241012573},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.7079135179519653},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6933928728103638},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.602576494216919},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.54837965965271},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4779624938964844},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46845149993896484},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4661380648612976},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.449947714805603},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2895931601524353},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.10063710808753967},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004943","descriptor_name":"Esophagogastric Junction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s12325-024-03069-4","doi":"https://doi.org/10.1007/s12325-024-03069-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-03069-4","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11929688","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11929688","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11929688/pdf/12325_2024_Article_3069.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:10741977","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11929688","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40025394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40025394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12325-024-03069-4","doi":"https://doi.org/10.1007/s12325-024-03069-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-024-03069-4","pdf_url":null,"source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408076804.pdf","grobid_xml":"https://content.openalex.org/works/W4408076804.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W2900604868","https://openalex.org/W2935936692","https://openalex.org/W2965580131","https://openalex.org/W3089110714","https://openalex.org/W3128646645","https://openalex.org/W3171517418","https://openalex.org/W3216240252","https://openalex.org/W4206757063","https://openalex.org/W4211255759","https://openalex.org/W4313236437","https://openalex.org/W4387849849","https://openalex.org/W4390469429"],"related_works":["https://openalex.org/W4412829908","https://openalex.org/W4406869892","https://openalex.org/W7213391338","https://openalex.org/W7212039369","https://openalex.org/W4405135059","https://openalex.org/W4406869197","https://openalex.org/W4382811483","https://openalex.org/W7116969686","https://openalex.org/W4410816711","https://openalex.org/W4327912882"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Results":[1],"of":[2,117],"the":[3,281],"global,":[4],"randomized,":[5],"phase":[6],"3":[7],"KEYNOTE-859":[8],"study":[9],"(N":[10],"=":[11],"1579)":[12],"showed":[13,290],"that":[14],"first-line":[15,286],"pembrolizumab":[16,92,142,175,204,226,264,287],"plus":[17,36,143,147,176,186,205,215,227,233,265,274,288,295],"chemotherapy":[18,37,177,187,206,216,228,266,289],"produced":[19],"a":[20],"statistically":[21],"significant":[22],"and":[23,97,115,130,267,297],"clinically":[24],"meaningful":[25],"improvement":[26],"in":[27,38,65,68,138,258,280,300,303],"overall":[28,282],"survival":[29,109],"(OS)":[30],"with":[31,40,73,95,263,272,278],"manageable":[32,298],"toxicity":[33],"versus":[34,178,207,229,244,293],"placebo":[35,94,146,185,214,232,273,294],"patients":[39,66,135,260,269,301],"locally":[41],"advanced":[42,76],"or":[43,53,77,82,93],"metastatic":[44,78],"human":[45],"epidermal":[46],"growth":[47],"factor":[48],"receptor":[49],"2":[50],"(HER2)-negative":[51],"gastric":[52,80],"gastroesophageal":[54,83],"junction":[55,84],"cancer.":[56],"This":[57],"subgroup":[58],"analysis":[59],"was":[60,103,159,166,197,223,237],"conducted":[61],"to":[62,90,153,242,249],"investigate":[63],"outcomes":[64,106],"enrolled":[67,137,302],"mainland":[69,139,304],"China.":[70,305],"METHODS:":[71],"Adults":[72],"previously":[74],"untreated":[75],"HER2-negative":[79],"cancer":[81],"adenocarcinoma":[85],"were":[86,136],"randomly":[87],"assigned":[88],"(1:1)":[89],"receive":[91],"fluoropyrimidine-":[96],"platinum-containing":[98],"chemotherapy.":[99,275],"The":[100],"primary":[101],"outcome":[102],"OS.":[104],"Secondary":[105],"included":[107],"progression-free":[108],"(PFS),":[110],"objective":[111],"response":[112,118],"rate":[113],"(ORR),":[114],"duration":[116],"(DOR),":[119],"all":[120],"assessed":[121],"per":[122],"RECIST":[123],"v1.1":[124],"by":[125],"blinded":[126],"independent":[127],"central":[128],"review,":[129],"safety.":[131],"RESULTS:":[132],"Overall,":[133],"236":[134],"China":[140],"(126":[141],"chemotherapy;":[144,234],"110":[145],"chemotherapy).":[148],"Median":[149,164,195],"time":[150],"from":[151,284],"randomization":[152],"database":[154],"cutoff":[155],"(October":[156],"3,":[157],"2022)":[158],"24.7":[160],"months":[161,168,180,199,209,239,246],"(range":[162,240,247],"15.3-38.9).":[163],"OS":[165],"15.9":[167],"(95%":[169,181,200,210],"confidence":[170],"interval":[171],"[CI]":[172],"13.2-19.2)":[173],"for":[174,184,203,213,225,231],"12.2":[179],"CI":[182,193,201,211,220],"10.6-14.1)":[183],"(hazard":[188],"ratio":[189],"[HR],":[190],"0.68;":[191],"95%":[192,219],"0.50-0.91).":[194],"PFS":[196],"8.1":[198],"6.9-9.6)":[202],"5.7":[208],"4.5-6.5)":[212],"(HR,":[217],"0.65;":[218],"0.48-0.88).":[221],"ORR":[222],"69.0%":[224],"45.5%":[230],"median":[235],"DOR":[236],"8.2":[238],"1.2+":[241],"34.6+)":[243],"5.5":[245],"1.3+":[248],"31.2+),":[250],"respectively.":[251],"Grade":[252],"3-5":[253],"treatment-related":[254],"adverse":[255],"events":[256],"occurred":[257],"82":[259],"(65.6%)":[261],"treated":[262,271],"54":[268],"(49.1%)":[270],"CONCLUSION:":[276],"Consistent":[277],"efficacy":[279],"population":[283],"KEYNOTE-859,":[285],"improved":[291],"efficacy,":[292],"chemotherapy,":[296],"safety":[299],"TRIAL":[306],"REGISTRATION:":[307],"Clinicaltrials.gov:":[308],"NCT03675737.":[309]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-03-02T00:00:00"}